CD155 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD155 monoclonal antibodies for research focused on understanding this important immune regulatory protein. CD155 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD155, also known as poliovirus receptor, plays a critical role in immune regulation and cell signaling. CD155 is involved in the activation of immune responses and has been implicated in tumor progression and immune evasion. Understanding CD155 function is essential for developing therapeutic strategies against cancers and viral infections. CD155 monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms in various research models. Researchers worldwide rely on CD155 monoclonal antibodies to advance their studies in immunology and oncology. CD155 monoclonal antibodies support cutting-edge research that contributes to scientific understanding and potential therapeutic developments. Santa Cruz Biotechnology monoclonal antibodies continue to support researchers in making meaningful discoveries that advance scientific knowledge and potential therapeutic applications.